The Effect of Xialiqi Capsule on Testosterone-Induced Benign Prostatic Hyperplasia in Rats

Table 2

Effects of XLQ capsule on prostate weight, body weight, and prostate index.

Group (n=10)	PW (mg)	BW (g)	PI (mg/g)	Inhibition
				PW	PI
Sham operation control	471.38±17.96	445.56±19.27	1.06±0.06	/	/
BPH model control	1326.15±60.20	459.44±21.10	2.89±0.18	/	/
High-dose XLQ Capsule	914.33±36.08^Δ	453.44±16.08	2.02±0.08^Δ	48.18	47.54
Low-dose XLQ Capsule	1099.76±46.28^Δ#	460.56±13.48	2.39±0.11^Δ#	26.49	27.32
Finasteride	817.25±53.99^Δ#▲	446.00±11.08	1.83±0.10^Δ#▲	59.54	57.92

: versus the sham operation control group, P<0.01; Δ: versus the model of BPH group, P<0.01; #: versus the high-dose XLQ group, P<0.01; ▲: versus the low-dose XLQ group, P<0.01; BW: body weight; PI: prostate index; PW: prostate weight; XLQ: Xialiqi.